Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010, Article ID 672137, 3 pages
http://dx.doi.org/10.1155/2010/672137
Clinical Study

Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol

Hematology and Hemotherapy Center, University of Campinas, SP, Rua Carlos Chagas 480, Campinas 13083-970, Brazil

Received 29 January 2010; Accepted 17 March 2010

Academic Editor: Jesus Fernando San Miguel

Copyright © 2010 Kátia B. Barbosa Pagnano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Fenaux, S. Chevret, A. Guerci et al., “Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia,” Leukemia, vol. 14, no. 8, pp. 1371–1377, 2000. View at Google Scholar · View at Scopus
  2. M. A. Sanz, P. Montesinos, E. Vellenga et al., “Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group,” Blood, vol. 112, no. 8, pp. 3130–3134, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. Lo-Coco, E. Ammatuna, P. Montesinos, and M. A. Sanz, “Acute promyelocytic leukemia: recent advances in diagnosis and management,” Seminars in Oncology, vol. 35, no. 4, pp. 401–409, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. Avvisati, F. Lo Coco, D. Diverio et al., “AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study,” Blood, vol. 88, no. 4, pp. 1390–1398, 1996. View at Google Scholar · View at Scopus
  5. W. H. Miller Jr., K. Levine, A. DeBlasio, S. R. Frankel, E. Dmitrovsky, and R. P. Warrell Jr., “Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA,” Blood, vol. 82, no. 6, pp. 1689–1694, 1993. View at Google Scholar · View at Scopus
  6. D. Diverio, V. Rossi, G. Avvisati et al., “Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter ‘AIDA’ trial,” Blood, vol. 92, no. 3, pp. 784–789, 1998. View at Google Scholar · View at Scopus
  7. R. H. Jácomo, R. A. M. Melo, F. R. Souto et al., “Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines,” Haematologica, vol. 92, no. 10, pp. 1431–1432, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus